| NPPV (n = 15) | CMV (n = 15) | P |
---|---|---|---|
Age, years, mean (SD) | 80 (5) | 73 (5) | 0.001 |
Male, n (%) | 12 (80) | 9 (60) | 0.427 |
BMI, Kg/m2, mean (SD) | 25 (4) | 26 (3) | 0.509 |
FEV1, % of pred., mean (SD)a | 30 (5) | 31 (5) | 0.866 |
FVC, % of pred., mean (SD)a | 39 (8) | 42 (8) | 0.262 |
PaO2, mmHg, mean (SD)a | 51 (3) | 54 (3) | 0.105 |
PaCO2, mmHg, mean (SD)a | 59 (5) | 57 (4) | 0.257 |
pH, mean (SD)a | 7.39 (0.02) | 7.40 (0.03) | 0.514 |
Charlson score, median (IQR) | 2 (1-2) | 1 (1-1) | 0.041 |
Exacerbations, median (IQR)b | 1.7 (0.9) | 1.1 (1.0) | 0.600 |
Antibiotic use, n (%)c | 5 (33.3) | 6 (40.0) | 0.705 |
DNR order, n (%) | 2 (13.3) | 0 (0.0) | 0.483 |
Pre-MV hospital, days median (IQR) | 1 (1-2) | 1 (1-2) | 0.646 |
RR, bpm, mean (SD) | 34 (4) | 36 (3) | 0.160 |
HR, bpm, mean (SD) | 102 (12) | 108 (12) | 0.224 |
PS, cmH2O, mean (SD) | 18 (4) | 17 (4) | 0.445 |